Compounds pharmaceutical compositions and methods for treatment of bacteremia and/or septicemia
AssigneesRamot at Tel-Aviv University Ltd., Yeda Research and Development Co. Ltd.
InventorsItzhak Ofek, Matityahu Fridkin, Haim Tsubery
Life of this patent
Estimating the term…
Abstract
Novel conjugates of bacterial outer membrane binding peptides, preferably having bacterial sensitization activity, and immune cells chemotactic peptides, and pharmaceutical compositions containing same useful in the treatment of bacteremia and/or septicemia following infection by gram negative bacteria administered alone or in combination with conventional antibiotics.
Claims86
A compound comprising a bacterial outer membrane binding peptide conjugated to an immune cell chemotactic peptide, said outer membrane binding peptide and said immune cell chemotactic peptide acting in synergy to provide a bacterial sensitizing activity.
A pharmaceutical composition for treatment of bacteremia and/or septicemia following infection by gram negative bacteria comprising, as an active ingredient a compound which comprises a bacterial outer cell membrane binding peptide conjugated to an immune cell chemotactic peptide, said outer membrane binding peptide and said immune cell chemotactic peptide acting in synergy to provide a bacterial sensitizing activity.
Use of a therapeutically effective amount of a compound which comprises a bacterial outer cell membrane binding peptide conjugated to an immune cell chemotactic peptide, said outer membrane binding peptide and said immune cell chemotactic peptide acting in synergy to provide a bacterial sensitizing activity for the manufacture of a medicament for treating bacteremia and/or septicemia in a subject following infection by gram negative bacteria.
Dependencies are inferred from the claim text.